Deep learning based low-activity PET reconstruction of [11C]PiB and [18F]FE-PE2I in neurodegenerative disorders

被引:11
|
作者
Daveau, Raphael Sura [1 ]
Law, Ian [1 ]
Henriksen, Otto Molby [1 ]
Hasselbalch, Steen Gregers [2 ]
Andersen, Ulrik Bjorn [1 ]
Anderberg, Lasse [1 ]
Hojgaard, Liselotte [1 ]
Andersen, Flemming Littrup [1 ]
Ladefoged, Claes Nohr [1 ]
机构
[1] Univ Copenhagen, Dept Clin Physiol & Nucl Med, Rigshosp, Copenhagen, Denmark
[2] Univ Copenhagen, Danish Dementia Res Ctr, Rigshosp, Copenhagen, Denmark
关键词
Parkinson's disease; F-18]FE-PE2I; Alzheimer's disease; C-11]PiB; Deep learning; PET denoising; DOPAMINE TRANSPORTER; DISEASE; CRITERIA;
D O I
10.1016/j.neuroimage.2022.119412
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Purpose: Positron Emission Tomography (PET) can support a diagnosis of neurodegenerative disorder by identifying disease-specific pathologies. Our aim was to investigate the feasibility of using activity reduction in clinical [F-18]FE-PE2I and [C-11]PiB PET/CT scans, simulating low injected activity or scanning time reduction, in combination with AI-assisted denoising. Methods: A total of 162 patients with clinically uncertain Alzheimer's disease underwent amyloid [C-11]PiB PET/CT and 509 patients referred for clinically uncertain Parkinson's disease underwent dopamine transporter (DAT) [F-18]FE-PE2I PET/CT. Simulated low-activity data were obtained by random sampling of 5% of the events from the list-mode file and a 5% time window extraction in the middle of the scan. A three-dimensional convolutional neural network (CNN) was trained to denoise the resulting PET images for each disease cohort. Results: Noise reduction of low-activity PET images was successful for both cohorts using 5% of the original activity with improvement in visual quality and all similarity metrics with respect to the ground-truth images. Clinically relevant metrics extracted from the low-activity images deviated < 2% compared to ground-truth values, which were not significantly changed when extracting the metrics from the denoised images. Conclusion: The presented models were based on the same network architecture and proved to be a robust tool for denoising brain PET images with two widely different tracer distributions (delocalized, ([C-11]PiB, and highly localized, [F-18]FE-PE2I). This broad and robust application makes the presented network a good choice for improving the quality of brain images to the level of the standard-activity images without degrading clinical metric extraction. This will allow for reduced dose or scan time in PET/CT to be implemented clinically.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECTa clinical comparison
    Mo, Susanna Jakobson
    Axelsson, Jan
    Jonasson, Lars
    Larsson, Anne
    Ogren, Mattias J.
    Ogren, Margareta
    Varrone, Andrea
    Eriksson, Linda
    Backstrom, David
    af Bjerken, Sara
    Linder, Jan
    Riklund, Katrine
    EJNMMI RESEARCH, 2018, 8
  • [42] Quantitative analysis of [18F]FE-PE2I binding to the dopamine transporter in Parkinson's disease
    Fazio, Patrik
    Svenningsson, Per
    Forsberg, Anton
    Jonsson, Erik
    Amini, Nahid
    Nakao, Ryuji
    Halldin, Christer
    Farde, Lars
    Varrone, Andrea
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [43] Age-related decline in dopamine transporter in human brain using PET with a new radioligand [18F]FE-PE2I
    Shingai, Yoshitoshi
    Tateno, Amane
    Arakawa, Ryosuke
    Sakayori, Takeshi
    Kim, WooChan
    Suzuki, Hidenori
    Okubo, Yoshiro
    ANNALS OF NUCLEAR MEDICINE, 2014, 28 (03) : 220 - 226
  • [44] Age-related decline in dopamine transporter in human brain using PET with a new radioligand [18F]FE-PE2I
    Yoshitoshi Shingai
    Amane Tateno
    Ryosuke Arakawa
    Takeshi Sakayori
    WooChan Kim
    Hidenori Suzuki
    Yoshiro Okubo
    Annals of Nuclear Medicine, 2014, 28 : 220 - 226
  • [45] An efficient one-step synthesis of [18F]FE-PE2I via nucleophilic fluorination of tosylatedprecursor
    Stepanov, Vladimir
    Krasikova, Raisa
    Raus, Liina
    Loog, Olavi
    Hiltunen, Jukka
    Halldin, Christer
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S506 - S506
  • [46] Longitudinal combined 11C UCB J and 18F FE PE2I PET imaging of presynaptic terminal loss in early Parkinson's disease
    Delva, A.
    Van Laere, K.
    Vandenberghe, W.
    MOVEMENT DISORDERS, 2022, 37 : S67 - S67
  • [47] [18F]FDG, [11C]PiB, and [18F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline
    Okonkwo, David O.
    Puffer, Ross C.
    Minhas, Davneet S.
    Beers, Sue R.
    Edelman, Kathryn L.
    Sharpless, Jane
    Laymon, Charles M.
    Lopresti, Brian J.
    Benso, Steven
    Puccio, Ava M.
    Pathak, Sudhir
    Ikonomovic, Milos D.
    Mettenburg, Joseph M.
    Schneider, Walter
    Mathis, Chester A.
    Mountz, James M.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [48] Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter
    Schou, Magnus
    Steiger, Carsten
    Varrone, Andrea
    Guilloteau, Denis
    Halldin, Christer
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4843 - 4845
  • [49] Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images
    Tolboom, Nelleke
    van der Flier, Wiesje M.
    Boverhoff, Jolanda
    Yaqub, Maqsood
    Wattjes, Mike P.
    Raijmakers, Pieter G.
    Barkhof, Frederik
    Scheltens, Philip
    Herholz, Karl
    Lammertsma, Adriaan A.
    van Berckel, Bart N. M.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (08): : 882 - 884
  • [50] Amylold deposition and glucose metabolism in focal cortical syndromes:: A comparative [11C]PIB and [18F]FDG PET study
    Rabinovici, Gil
    Furst, Ansgar
    Mormino, Elizabeth
    Wong, Alana T.
    Madison, Cindee
    Miller, Bruce
    Tempini, Maria Gorno
    Jagust, William
    NEUROLOGY, 2008, 70 (11) : A441 - A441